Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4630758 Target Snapshot

5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2 · PROTEIN COMPLEX · Homo sapiens

17Compounds
9Assays
0Approved Drugs
174.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28223. Use UniProt P28223 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28223 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2 as ChEMBL target CHEMBL4630758, mapped to UniProt P28223. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4630758
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28223
5-hydroxytryptamine receptor 2A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2 is the right protein anchor across sources, using UniProt P28223 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 2A
UniProt AccessionP28223
Component TypeProtein
Sequence Length471 aa

5-hydroxytryptamine receptor 2A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2, mapped to UniProt P28223. ChEMBL maps the protein component as 5-hydroxytryptamine receptor 2A. Sequence length is 471 aa.

Mapped IDP28223
Review name5-hydroxytryptamine receptor 2A/Metabotropic glutamate receptor 2
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5088.0
KI36.0
EC5050.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4638006 8.52 Ki 3.0 Preclinical
CHEMBL4638006 8.27 IC50 5.4 Preclinical
CHEMBL4636980 8.19 Ki 6.457 Preclinical
CHEMBL489624 8.04 IC50 9.12 Preclinical
CHEMBL4636980 7.8 IC50 16.0 Preclinical
CHEMBL2206440 7.72 EC50 19.0 Preclinical
CHEMBL4646555 7.72 EC50 19.0 Preclinical
CHEMBL4632373 7.62 EC50 23.99 Preclinical
CHEMBL4646835 7.6 EC50 25.0 Preclinical
CHEMBL4643961 7.51 EC50 30.9 Preclinical
Distribution

pChEMBL Value Distribution

26
5.0
13
5.5
21
6.0
39
6.5
6
7.0
25
7.5
10
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

9
Total Assays
17
Tested Compounds
2
Assay Types
Functional — 7 assays, 17 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 7 17 6.4
Binding — 2 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 9 7.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine